Comparison of the Systemic Effects of Fluticasone Propionate and Triamcinolone Acetonide Administered in Equipotent Doses in Children with Asthma

Pediatric Asthma, Allergy and Immunology

Volumn 16, Issue 4, 2003, Pages 283-293

  Raissy, Hengameh H ^a   Wright, Heather ^b   Crowley, Mark ^a   Marshik, Patricia ^c   Colon Semidy, Angel ^d   Kelly, H William ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FLUTICASONE PROPIONATE; HYDROCORTISONE; NITRIC OXIDE; OSTEOCALCIN; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADRENAL GLAND; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BODY SURFACE; BONE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; MALE; OPEN STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; UNITED STATES;

EID: 0742306017     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/088318703322751336     Document Type: Article

References (49)

1. NHLBI, National Asthma Education Program, Expert Panel Report. Guidelines for the diagnosis and management of asthma. Publication No.97-4051. Bethesda, MD: US Department of Health and Human Services; 1997.
2. Kelly HW. Establishing a therapeutic index for the inhaled corticosteroids: part 1. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids. J Allergy Clin Immunol 1998; 102:S36-S51.
3. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 1998; 157(suppl):S1-S53.
4. Toogood JH. Side effects of inhaled corticosteroids. J Allergy Clin Immunol 1998; 102:705-713.
5. Wilson AM, Lipworth BJ. Short-term dose-response relationships for the relative systemic effect of oral prednisolone and inhaled fluticasone in asthmatic adults. Br J Clin Pharmacol 1999; 48:579-585.
6. Wilson AM, Sims EJ, Lipworth BJ. Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment. Clin Endocrinol 1999; 50:329-335.
7. Wilson AM, McFarlane LC, Lipworth BJ. Systemic bioactivity of oral prednisolone and nebulized budesonide in adult asthmatics. Chest 1998; 114:1022-1027.
8. Toogood JH, White FA, Baskerville JC, Fraher LJ, Jennings B. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler. J Allergy Clin Immunol 1997; 99:186-193.
9. Grebe SK, Feek CM, Durham JA, Kljakovic M, Cooke RR. Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner. Clin Endocrinol 1997; 47:297-304.
10. Malo JL, Cartier A, Ghezzo H, Mark S, Brown J, Laviolette M, Boulet LP. Skin bruising, adrenal function and marker of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone. Eur Respir J 1999; 13:993-998.
11. Hedlin G, Svedmyr J, Ryden AC. Systemic effects of a short course of beclomethasone compared with high-dose inhaled budesonide in early childhood asthma. Acta Paediatr 1999; 88:48-51.
12. Wolthers OD, Hansen M, Juul A, Nielsen HK, Pedersen S. Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticoids. Pediatr Res 1997; 41:44-50.
13. Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, Young DA, Spahn JD. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003; 142:469-475.
14. Condemi JJ, Chervinsky P, Goldstein MF, Ford LB, Berger WE, Ayars GH, et al. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. J Allergy Clin Immunol 1997; 100:467-474.
15. Wilson AM, Clark DJ, McFarlane L, Lipworth BJ. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers. Eur J Clin Pharmacol 1997; 53:33-37.
16. O'Byrne PM, Pedersen S. Measuring efficacy and safety of different inhaled corticosteroid preparation. J Allergy Clin Immunol 1998; 102:879-886.
17. Lipworth BJ, Wilson AM. Dose response to inhaled corticosteroids: benefits and risks. Sem Respir Crit Care Med 1998; 1:625-646.
18. Bisgaard H, Nielsen MD, Andersen B, Andersen P, Foged N, Fugisang G, et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol 1988; 81:1088-1095.
19. Pedersen S, Fuglsang G. Urine cortical excretion in children with high dose of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J 1988; 1:433-435.
20. Prifits K, Milner AD, Conway E, Honour JW. Adrenal function in asthma. Arch Dis Child 1990; 65:838-840.
21. Wyatt R, Waschek J, Weinberger M, Sherman B. Effects of inhaled beclomethasone dipropionate and alternate-day prednisone in pituitary-adrenal function in children with chronic asthma. N Engl J Med 1978; 299:1387-1392.
22. Tabachnik E, Zadik Z. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. J Pediatr 1991; 11:294-297.
23. Nicolaizik WH, Marchant JL, Preece MA, Warner JO. Endocrine and lung function in asthmatic children on inhaled corticosteroids. Am J Respir Crit Care Med 1994; 150:624-628.
24. Goldberg S, Algur N, Levi M, Brukheimer E, Hirsch HJ, Branski D and Kerem E. Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device. Ann Allergy Asthma Immunol 1996; 76:234-238.
25. Gomez MT, Malozowski S, Winterer J, Vamvaakopoulos NC, Chrousos GP. Urinary free cortisol values in children and adolescents. J Pediatr 1991; 118:256-268.
26. Martin RJ, Szefler SJ, Chinchilli VM, Kraft M, Dolovich M, Boushey HA, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002; 165:1377-1383.
27. Tinkleman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92:64-77.
28. Doull JM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995; 151:1715-1719.
29. Eagon JJ, Maden C, Karla S, Adams JE, Eastell R, Woodcock AA. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. Eur Respir J 1999; 13:1267-1275.
30. Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, Swinkels LM, Herwaarden CL. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Am J Respir Crit Care Med 1996; 153:924-930.
31. Pauwels RA, Yernault JC, Demedts MG, Geusens P. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group. Am J Respir Crit Care Med 1998; 157:827-832.
32. Sorva R, Turpeinen M, Juntunen-Backman K, Karonen S-L, Sorva A. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol 1992; 90:808-815.
33. Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatics children treated with oral prednisolone or inhaled budesonide. Pediatr Pulmonol 1993; 16:341-346.
34. Konig P, Hillman L, Cervantes C, Levine C, Maloney C, Douglass B, Johnson L, Allen S. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr 1993; 122:219-226.
35. Priftis K, Vosaki I, Papadimitrou A, Athanasopoulou H, Georgacopoulou C, Zervos J, et al. Effects of long-term treatment with inhaled steroids on bone metabolism in asthmatic children. Eur Respir J 1994; 7:28s.
36. Doull IJM, White M, Freezer NJ, Holgate ST. Markers of bone metabolism in asthmatic children receiving inhaled corticosteroids. Eur Respir J 1994; 7:28s.
37. Birkbaek NH, Esberg G, Andersen K, Woltthers O, Hassanger C. Bone and Collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child 1995; 73:524-527.
38. Hoekx JCM, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of a 400 μg/day. Eur Respir J 1996; 9:2263-2272.
39. Crowley S, Trivedi P, Risteli L, Hindmarsh PC, Brook CG. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroid. J Pediatr 1998; 132:409-413.
40. Rao R, Gregson RK, Jones AC, Miles EA, Campbell MJ, Warner JO. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone. Eur Respir J 1999; 13:87-94.
41. Drazen JM, Israel E, Boushey HA, Chinchilli VM, Fahey JV, Fish JE, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996; 335:841-847.
42. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163:1693-1722.
43. Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999; 54:108-114.
44. Silkoff PE, McClean P, Spino M, Erlich L, Slutsky AS, Zamel N. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001; 119:1322-1328.
45. Nielsen LP, Dahl D. Therapeutic ratio of inhaled corticosteroids in adult asthma, a dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. Am J Respir Crit Care Med 2000; 162:2053-2057.
46. McCubbin MM, Milavetz G, Grandgeorge S, Weinberger M, Ahrens R, Sargent C, Vaughan LM. A bioassay for topical and systemic effect of three inhaled corticosteroids. Clin Pharmacol Ther 1995; 57:455-460.
47. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109:410-418.
48. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996; 9:196-201.
49. Spallarossa D, Battistini E, Silvestri M, Sabatini F, Biraghi MG, Rossi GA. Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma. J Asthma 2001; 38:545-553.